Franklin Resources
CTNM

Franklin Resources’s Contineum Therapeutics CTNM Stock Holding History

Franklin Resources’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24M Sell
1,839,227
-40,140
-2% -$538K 0.01% 915
2025
Q4 		$21.5M Buy
1,879,367
+223,819
+14% +$2.55M 0.01% 937
2025
Q3 		$19.5M Sell
1,655,548
-43,277
-3% -$349K ﹤0.01% 956
2025
Q2 		$6.74M Buy
1,698,825
+122,644
+8% +$533K ﹤0.01% 1262
2025
Q1 		$11M Buy
1,576,181
+130,616
+9% +$1.19M ﹤0.01% 1073
2024
Q4 		$21.2M Sell
1,445,565
-1,985
-0.1% -$31.4K 0.01% 897
2024
Q3 		$23.6M Buy
1,447,550
+820,542
+131% +$15.7M 0.01% 844
2024
Q2 		$11M Buy
+627,008
New +$10.1M ﹤0.01% 1037

Other funds holding CTNM

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return